Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Xarelto receives FDA approval

July 4, 2011 Sales and Marketing Bayer, Eliquis, Johnson & Johnson, Pradaxa, Xarelto, anticoagulant

Bayer and Johnson & Johnson’s oral blood thinner Xarelto has been approved in the US for the prevention of deep …
News

Nycomed gains new European licence for cancer pain spray

July 4, 2011 Sales and Marketing Nycomed, cancer pain, pain therapeutics

The European Commission has approved Nycomed’s Instanyl in a single-dose nasal spray for the treatment of breakthrough pain in cancer …
News
reckitt_benckiser_camillo_pane

Reckitt Benckiser promotes Camillo Pane

July 4, 2011 Sales and Marketing appointment, sales and marketing

Reckitt Benckiser’s UK general manager Camillo Pane has been promoted to senior vice president – global category officer healthcare. Reporting …
Appointment
Eli Lilly & Company

Lilly prepares late-stage pipeline boost

July 1, 2011 Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology

Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …
News

EMA extends Avastin breast cancer licence

July 1, 2011 Sales and Marketing avastin, breast cancer, metastatic breast cancer

The EMA has extended the breast cancer licence for Roche’s Avastin after initially restricting the drug’s use. The decision comes …
News

Almirall appoints new general manager for Germany

July 1, 2011 Research and Development, Sales and Marketing Almirall, appointment, research and development, sales and marketing

Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …
News
Roche's Avastin (bevacizumab)

FDA advisers reject Avastin appeal

June 30, 2011 Sales and Marketing FDA, avastin

An FDA advisory panel has refused to back Roche’s Avastin in advanced breast cancer after ruling it neither safe nor …
News
Roche's Tarceva (erlotinib)

Tarceva fails to win NICE backing

June 30, 2011 Sales and Marketing NICE, Tarceva

NICE has decided not to recommend Roche’s Tarceva because of uncertainty over how long the lung cancer drug can extend …
News

The growing role of regulatory affairs

June 30, 2011 Business Services, Research and Development, Sales and Marketing regulatory affairs, topra

Some years ago, regulatory affairs (RA) was seen by some as merely a ‘front office’ function, providing a necessary interface …
Feature

New medicine approvals slumped to record low in 2010

June 29, 2011 Research and Development, Sales and Marketing drug sales, new drug approvals, research

There was a major slide in medicine approvals last year, compounding a difficult and ominous period for the industry. Only …
News

Treatment flexibility will improve adherence in diabetes, study suggests

June 29, 2011 Research and Development, Sales and Marketing diabetes, insulin

A third of patients with diabetes admit to regularly missing or not taking insulin treatment three days a month, according …
News

Greek debt hits pharma deliveries

June 29, 2011 Sales and Marketing Greece

The debt crisis afflicting Greece is starting to affect the country’s hospitals as pharma companies refuse to deliver drugs. Roche …
News
Novartis

Regulators back Novartis’ Votubia

June 28, 2011 Sales and Marketing Novartis, Votubia, everolimus

Novartis’ drug Votubia has been recommended by regulators to treat a disease for which the only current option in Europe …
News

Service Insight: Submission development and market access

June 28, 2011 Sales and Marketing Service Insight

SERVICE INSIGHT A successful health technology assessment is critical for market access in the UK. However, submissions that don’t follow …
Feature

Sanofi appoints Peter Guenter senior VP, Europe

June 28, 2011 Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing

Sanofi has promoted Peter Guenter to senior vice president, Europe, with effect from 15 July. He is currently general manager …
Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026